![]()
|
|
||||||||
J. Biol. Chem., Vol. 281, Issue 6, 3651-3659, February 10, 2006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Peptide*






1
From the
Laboratory of Molecular Immunoregulation, Center for Cancer Research, NCI, National Institutes of Health, Frederick, Maryland 21702, ||Image Analysis Laboratory and ¶Basic Research Program, SAIC, NCI, National Institutes of Health, Frederick, Maryland 21702, and
School of Agriculture and Biology, Shanghai Jiaotong University, 201101 Shanghai, China
The human G-protein-coupled formyl peptide receptor-like 1 (FPRL1) and its mouse homologue mFPR2 mediate the chemotactic activity of a variety of polypeptides associated with inflammation and bacterial infection, including the 42-amino acid form of amyloid
peptide (A
42), a pathogenic factor in Alzheimer disease. Because mFPR2 was inducible in mouse microglial cells by proinflammatory stimulants, such as bacterial lipopolysaccharide, a ligand for the Toll-like receptor 4 (TLR4), we investigated the role of TLR2 in the regulation of mFPR2. We found that a TLR2 agonist, peptidoglycan (PGN) derived from Gram-positive bacterium Staphylococcus aureus, induced considerable mFpr2 mRNA expression in a mouse microglial cell line and primary microglial cells. This was associated with a markedly increased chemotaxis of the cells in response to mFPR2 agonist peptides. In addition, activation of TLR2 markedly enhanced mFPR2-mediated uptake of A
42 by microglia. Studies of the mechanistic basis showed that PGN activates MAPK and I
B
, and the effect of PGN on induction of mFPR2 was dependent on signaling pathways via ERK1/2 and p38 MAPKs. The use of TLR2 on microglial cells by PGN was supported by the fact that N9 cells transfected with short interfering RNA targeting mouse TLR2 failed to show increased expression of functional mFPR2 after stimulation with PGN. Our results demonstrated a potentially important role for TLR2 in microglial cells of promoting cell responses to chemoattractants produced in lesions of inflammatory and neurodegenerative diseases in the brain.
Received for publication, July 25, 2005 , and in revised form, December 8, 2005.
* This work was supported in part by NCI Contract NO1-CO-12400 from the National Institutes of Health. Animal care was provided in accordance with the procedures outlined in the "Guide for the Care and Use of Laboratory Animals" (National Institutes of Health Publication No. 86-23, 1985). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 To whom correspondence should be addressed: Laboratory of Molecular Immunoregulation, Center for Cancer Research, NCI, National Institutes of Health, Bldg. 560, Rm. 31-40, Frederick, MD 21702-1201. Tel.: 301-846-6979; Fax: 301-846-7042; E-mail: wangji{at}mail.ncifcrf.gov.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
H. J. Yoon, S.-B. Jeon, I.-H. Kim, and E. J. Park Regulation of TLR2 Expression by Prostaglandins in Brain Glia J. Immunol., June 15, 2008; 180(12): 8400 - 8409. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Chen, L. Zhang, J. Huang, W. Gong, N. M. Dunlop, and J. M. Wang Cooperation between NOD2 and Toll-like receptor 2 ligands in the up-regulation of mouse mFPR2, a G-protein-coupled A{beta}42 peptide receptor, in microglial cells J. Leukoc. Biol., June 1, 2008; 83(6): 1467 - 1475. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Richard, M. Filali, P. Prefontaine, and S. Rivest Toll-Like Receptor 2 Acts as a Natural Innate Immune Receptor to Clear Amyloid {beta}1-42 and Delay the Cognitive Decline in a Mouse Model of Alzheimer's Disease J. Neurosci., May 28, 2008; 28(22): 5784 - 5793. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Watanabe, M. Ichiki, A. Shiratsuchi, and Y. Nakanishi TLR2-Mediated Survival of Staphylococcus aureus in Macrophages: A Novel Bacterial Strategy against Host Innate Immunity J. Immunol., April 15, 2007; 178(8): 4917 - 4925. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhao, K. Yokota, K. Ayada, Y. Yamamoto, T. Okada, L. Shen, and K. Oguma Helicobacter pylori heat-shock protein 60 induces interleukin-8 via a Toll-like receptor (TLR)2 and mitogen-activated protein (MAP) kinase pathway in human monocytes J. Med. Microbiol., February 1, 2007; 56(2): 154 - 164. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Chen, P. Iribarren, J. Huang, L. Zhang, W. Gong, E. H. Cho, S. Lockett, N. M. Dunlop, and J. M. Wang Induction of the Formyl Peptide Receptor 2 in Microglia by IFN-{gamma} and Synergy with CD40 Ligand J. Immunol., February 1, 2007; 178(3): 1759 - 1766. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tahara, H.-D. Kim, J.-J. Jin, J. A. Maxwell, L. Li, and K.-i. Fukuchi Role of toll-like receptor signalling in A{beta} uptake and clearance Brain, November 1, 2006; 129(11): 3006 - 3019. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |